Biological composition, efficacy and primary efficacy endpoint of SARS-CoV-2 vaccines: A special communication
Description
Severe acute respiratory syndrome coronavirus 2 was first reported in Wuhan, China, in late December 2019 and rapidly spread out globally, affecting 130 million individuals and starting a global pandemic. An efficacious vaccine is considered an